Hajid bin Lafi Al-Harbi, a resident of the Jdaidet Arar port located on the Saudi-Iraqi border, enjoys reading “Okaz.” He mentioned that he has subscribed to the newspaper for more than 15 years, in which his relationship with the first newspaper in the Kingdom and the Gulf was strengthened – as he said – because of its credibility and diversity. Comprehensiveness and follow-up behind the news.
Read next
Health
GLP-1 Class Drugs Expand into Broader Metabolic and Cardiovascular Applications
Clinical trials indicate GLP-1 receptor agonists offer benefits beyond glycemic control, impacting insurance coverage frameworks globally.
Health
AI-Driven Drug Discovery Accelerates Phase I Clinical Pipelines
Biopharmaceutical firms utilizing machine learning models report a 30% reduction in early-stage molecule discovery timelines.
Health
GLP-1 Class Therapies Alter Long-Term Healthcare Capital Expenditures
The rapid adoption of anti-obesity medications is restructuring market projections for cardiovascular and metabolic disease treatments.
Health
Predictive Analytics Integration Streamlines Hospital Operational Workflows
Healthcare providers are deploying predictive bed management and staffing algorithms to optimize patient admission rates.
Health
GLP-1 Supply Constraints Drive Strategic Investment in Peptide Synthesis
Pharmaceutical giants are pouring billions into manufacturing facilities to clear persistent shortages of obesity and diabetes medications.
Health
GLP-1 Therapeutics Reshape Corporate Health Benefit Strategies
Employers revise prescription drug coverage as anti-obesity medication costs surge across self-insured plans.